Why America Is Running Out of Execution Drugs: The Global Story Podcast

Last week, Tennessee attempted to execute Christa Pike, a convicted murderer who had spent three decades on death row. However, the execution did not go as planned: after being injected with two lethal doses of pentobarbital, Pike remained alive. She was subsequently taken to a hospital by ambulance. This botched execution is not an isolated incident; it highlights a growing problem in the United States. One major reason for these failures is that the drugs needed for lethal injection have become increasingly difficult for prison officials to obtain. Pharmaceutical companies, particularly in Europe, have refused to supply their products for use in executions, citing ethical concerns. As a result, states have resorted to untested drug combinations and secret suppliers, leading to gruesome outcomes. The Global Story podcast explores the implications of this shortage, including the legal and moral questions it raises. As executions become more difficult to carry out, the death penalty itself is being called into question. The episode examines how the scarcity of drugs is reshaping the debate over capital punishment in America.